JP2022527395A5 - - Google Patents

Info

Publication number
JP2022527395A5
JP2022527395A5 JP2021559883A JP2021559883A JP2022527395A5 JP 2022527395 A5 JP2022527395 A5 JP 2022527395A5 JP 2021559883 A JP2021559883 A JP 2021559883A JP 2021559883 A JP2021559883 A JP 2021559883A JP 2022527395 A5 JP2022527395 A5 JP 2022527395A5
Authority
JP
Japan
Application number
JP2021559883A
Other languages
Japanese (ja)
Other versions
JP2022527395A (ja
JPWO2020210308A5 (https=
JP7577682B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/027203 external-priority patent/WO2020210308A1/en
Publication of JP2022527395A publication Critical patent/JP2022527395A/ja
Publication of JPWO2020210308A5 publication Critical patent/JPWO2020210308A5/ja
Publication of JP2022527395A5 publication Critical patent/JP2022527395A5/ja
Application granted granted Critical
Publication of JP7577682B2 publication Critical patent/JP7577682B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021559883A 2019-04-10 2020-04-08 ガレクチン-3の低分子阻害剤 Active JP7577682B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962831753P 2019-04-10 2019-04-10
US62/831,753 2019-04-10
PCT/US2020/027203 WO2020210308A1 (en) 2019-04-10 2020-04-08 Small molecule inhibitors of galectin-3

Publications (4)

Publication Number Publication Date
JP2022527395A JP2022527395A (ja) 2022-06-01
JPWO2020210308A5 JPWO2020210308A5 (https=) 2023-04-17
JP2022527395A5 true JP2022527395A5 (https=) 2023-04-17
JP7577682B2 JP7577682B2 (ja) 2024-11-05

Family

ID=70476468

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021559883A Active JP7577682B2 (ja) 2019-04-10 2020-04-08 ガレクチン-3の低分子阻害剤

Country Status (6)

Country Link
US (1) US12269819B2 (https=)
EP (1) EP3953349A1 (https=)
JP (1) JP7577682B2 (https=)
KR (1) KR102890853B1 (https=)
CN (1) CN113710665A (https=)
WO (1) WO2020210308A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114206893A (zh) 2019-08-09 2022-03-18 爱杜西亚药品有限公司 (杂)芳基-甲基-硫代-β-D-吡喃半乳糖苷衍生物
EP4010348B1 (en) 2019-08-09 2023-12-20 Idorsia Pharmaceuticals Ltd (2-acetamidyl)thio-beta-d-galactopyranoside derivatives
JP7604457B2 (ja) 2019-08-15 2024-12-23 イドルシア・ファーマシューティカルズ・リミテッド 2-ヒドロキシシクロアルカン-1-カルバモイル誘導体
CA3148365A1 (en) 2019-08-29 2021-03-04 Martin Bolli Alpha-d-galactopyranoside derivatives
EP4149939A1 (en) * 2020-05-11 2023-03-22 Bristol-Myers Squibb Company Small molecule inhibitors of galectin-3
ES3014851T3 (en) 2020-10-06 2025-04-25 Idorsia Pharmaceuticals Ltd Spiro derivatives of alpha-d-galactopyranosides
KR20230104190A (ko) * 2020-11-02 2023-07-07 이도르시아 파마슈티컬스 리미티드 갈렉틴-3 억제 2-히드록시시클로알칸-1-카르바모일 유도체
KR20230145111A (ko) 2021-02-09 2023-10-17 이도르시아 파마슈티컬스 리미티드 히드록시헤테로시클로알칸-카르바모일 유도체
PL4301748T3 (pl) * 2021-03-03 2025-09-08 Idorsia Pharmaceuticals Ltd Triazolilo-metylo podstawione pochodne alfa-d-galaktopiranozydu

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401301D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel 3-triazolyl-galactoside inhibitors of galectins
SE0401300D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel Galactoside Inhibitors of Galectins
US9021050B2 (en) 2012-08-31 2015-04-28 Yume, Inc. Network service system and method with off-heap caching
US8828971B2 (en) 2012-10-10 2014-09-09 Galectin Therapeutics, Inc. Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
JP2015535233A (ja) 2012-10-31 2015-12-10 ガレクト・バイオテック・エイビイ ガレクチン−3のガラクトシド阻害剤及び肺線維症のためのその使用
JP6904906B2 (ja) 2015-01-30 2021-07-21 ガレクト・バイオテック・エイビイ ガレクチンの新規なガラクトシド阻害剤
JP6844991B2 (ja) 2015-11-10 2021-03-17 サンコ テキスタイル イスレットメレリ サン ベ ティク エーエスSanko Tekstil Isletmeleri San. Ve Tic. A.S. ジッパーを有する伸縮性衣類の製法
CA3062648A1 (en) 2017-05-12 2018-11-15 Galectin Sciences, Llc Compounds for the prevention and treatment of diseases and the use thereof
US20200061095A1 (en) * 2017-05-12 2020-02-27 Galectin Sciences, Llc Compounds for the Treatment of Systemic Insulin Resistance Disorders and the Use Thereof
WO2019067702A1 (en) 2017-09-27 2019-04-04 Bristol-Myers Squibb Company INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3

Similar Documents

Publication Publication Date Title
JP2022527395A5 (https=)
JP2023547241A5 (https=)
JP1703520S (https=)
JP2023525527A5 (https=)
CN305700211S (https=)
CN306113495S (https=)
CN306111041S (https=)
CN306106645S (https=)
CN306103892S (https=)
CN306100746S (https=)
CN306079949S (https=)
CN306079364S (https=)
CN306076470S (https=)
CN306075896S (https=)
CN306072894S (https=)
CN306064635S (https=)
CN306056033S (https=)
CN305453159S9 (https=)
CN306039468S (https=)
CN306038135S (https=)
CN305581405S (https=)
CN306034095S (https=)
CN305536202S (https=)
CN305536179S (https=)
CN305535367S (https=)